Literature DB >> 16216549

Pulmonary surfactant function is abolished by an elevated proportion of cholesterol.

Lasantha Gunasekara1, Samuel Schürch, W Michael Schoel, Kaushik Nag, Zoya Leonenko, Michael Haufs, Matthias Amrein.   

Abstract

A molecular film of pulmonary surfactant strongly reduces the surface tension of the lung epithelium-air interface. Human pulmonary surfactant contains 5-10% cholesterol by mass, among other lipids and surfactant specific proteins. An elevated proportion of cholesterol is found in surfactant, recovered from acutely injured lungs (ALI). The functional role of cholesterol in pulmonary surfactant has remained controversial. Cholesterol is excluded from most pulmonary surfactant replacement formulations, used clinically to treat conditions of surfactant deficiency. This is because cholesterol has been shown in vitro to impair the surface activity of surfactant even at a physiological level. In the current study, the functional role of cholesterol has been re-evaluated using an improved method of evaluating surface activity in vitro, the captive bubble surfactometer (CBS). Cholesterol was added to one of the clinically used therapeutic surfactants, BLES, a bovine lipid extract surfactant, and the surface activity evaluated, including the adsorption rate of the substance to the air-water interface, its ability to produce a surface tension close to zero and the area compression needed to obtain that low surface tension. No differences in the surface activity were found for BLES samples containing either none, 5 or 10% cholesterol by mass with respect to the minimal surface tension. Our findings therefore suggest that the earlier-described deleterious effects of physiological amounts of cholesterol are related to the experimental methodology. However, at 20%, cholesterol effectively abolished surfactant function and a surface tension below 15 mN/m was not obtained. Inhibition of surface activity by cholesterol may therefore partially or fully explain the impaired lung function in the case of ALI. We discuss a molecular mechanism that could explain why cholesterol does not prevent low surface tension of surfactant films at physiological levels but abolishes surfactant function at higher levels.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16216549     DOI: 10.1016/j.bbalip.2005.09.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  35 in total

1.  Combined and independent action of proteins SP-B and SP-C in the surface behavior and mechanical stability of pulmonary surfactant films.

Authors:  David Schürch; Olga L Ospina; Antonio Cruz; Jesús Pérez-Gil
Journal:  Biophys J       Date:  2010-11-17       Impact factor: 4.033

2.  An elevated level of cholesterol impairs self-assembly of pulmonary surfactant into a functional film.

Authors:  Zoya Leonenko; Simardeep Gill; Svetlana Baoukina; Luca Monticelli; Jana Doehner; Lasantha Gunasekara; Florian Felderer; Mathias Rodenstein; Lukas M Eng; Matthias Amrein
Journal:  Biophys J       Date:  2007-05-04       Impact factor: 4.033

3.  The molecular mechanism of monolayer-bilayer transformations of lung surfactant from molecular dynamics simulations.

Authors:  Svetlana Baoukina; Luca Monticelli; Matthias Amrein; D Peter Tieleman
Journal:  Biophys J       Date:  2007-08-17       Impact factor: 4.033

4.  Roles of the Mevalonate Pathway and Cholesterol Trafficking in Pulmonary Host Defense.

Authors:  Kristin A Gabor; Michael B Fessler
Journal:  Curr Mol Pharmacol       Date:  2017       Impact factor: 3.339

5.  A modified squeeze-out mechanism for generating high surface pressures with pulmonary surfactant.

Authors:  Eleonora Keating; Yi Y Zuo; Seyed M Tadayyon; Nils O Petersen; Fred Possmayer; Ruud A W Veldhuizen
Journal:  Biochim Biophys Acta       Date:  2011-12-21

6.  Differential effects of cholesterol and budesonide on biophysical properties of clinical surfactant.

Authors:  Hong Zhang; Yi E Wang; Charles R Neal; Yi Y Zuo
Journal:  Pediatr Res       Date:  2012-02-15       Impact factor: 3.756

7.  Probing perturbation of bovine lung surfactant extracts by albumin using DSC and 2H-NMR.

Authors:  Kaushik Nag; Kevin M W Keough; Michael R Morrow
Journal:  Biophys J       Date:  2006-02-24       Impact factor: 4.033

Review 8.  Overcoming rapid inactivation of lung surfactant: analogies between competitive adsorption and colloid stability.

Authors:  Joseph A Zasadzinski; Patrick C Stenger; Ian Shieh; Prajna Dhar
Journal:  Biochim Biophys Acta       Date:  2009-12-22

9.  Combined effect of synthetic protein, Mini-B, and cholesterol on a model lung surfactant mixture at the air-water interface.

Authors:  Aishik Chakraborty; Erica Hui; Alan J Waring; Prajnaparamita Dhar
Journal:  Biochim Biophys Acta       Date:  2016-01-15

10.  Atomic force microscopy studies of functional and dysfunctional pulmonary surfactant films, II: albumin-inhibited pulmonary surfactant films and the effect of SP-A.

Authors:  Yi Y Zuo; Seyed M Tadayyon; Eleonora Keating; Lin Zhao; Ruud A W Veldhuizen; Nils O Petersen; Matthias W Amrein; Fred Possmayer
Journal:  Biophys J       Date:  2008-06-06       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.